Although differential screening-selected gene aberrative in neuroblastoma (DAN, official symbol NBL1) is the founding member of the DAN subfamily of bone morphogenetic protein (BMP) antagonists, its antagonizing targets, gene regulation, and physiological functions remain unclear. Using diverse cell expression systems, we found that the generation of bioactive DAN is likely to be cell type specific. Unlike other phylogenetically close members, which are covalently linked homodimers, DAN forms a noncovalently linked homodimer during folding. Purified recombinant DAN specifically blocked signaling of BMP2 and BMP4 but not that of other ovarian-expressed transforming growth factor-beta members. Although widely distributed in many organs, DAN transcript level was periodically regulated by gonadotropins. Ovarian microdissection indicated that NBL1 (DAN) mRNA is mainly expressed in granulosa cells, where its transcript level is up-regulated by the gonadotropin-driven cAMP cascade. We further investigated the local regulation and ovarian functions of DAN. NBL1 (DAN) mRNA expression in granulosa cells was up-regulated by oocytederived growth differentiation factor 9 (GDF9), whereas treatment with DAN significantly reversed the inhibitory effect of BMP4 on follicle-stimulating hormone-induced progesterone production in cultured granulosa cells. Our findings suggest the DAN gradient in granulosa cells, established by oocyte-derived GDF9, may serve as an antagonist barrier that modulates the actions of theca-derived BMP4 and granulosa/theca-derived BMP2 during folliculogenesis both spatially and temporally.
INTRODUCTION
Bone morphogenetic proteins (BMPs) are a group of phylogenetically conserved molecules that belong to the transforming growth factor-b (TGFB) superfamily [1, 2] . Genomic analysis in mammals has indicated that the BMP family contains more than 20 members. In addition to the fundamental function of BMPs, directing bone formation and body patterning, several other paralogs in this family exhibit the ability to control the growth and differentiation of diverse tissues and thus are also named growth differentiation factors (GDFs) [3, 4] . Despite differences in sequence and function, most BMP members bind to common type I and type II serine/ threonine kinase receptor heterodimers, which then further activate the homologs of mothers against decapentaplegic (SMAD) signaling.
Current studies indicate that many BMP members are coexpressed in the same organ, even in the same cell type. For example, in the ovary, oocytes are able to express GDF9, BMP15, and BMP6; granulosa cells are able to secrete BMP2, BMP5, and BMP6; and theca interstitial cells are known to produce at least BMP4, BMP2, BMP7, and GDF10 [5, 6] . BMP molecules are known to signal through common receptors; therefore, one may expect that the mechanisms that regulate their spatial and temporal expression, as well as their activity, are important in allowing these BMP molecules to function coordinately but not redundantly in the same organ. Among these mechanisms, the modulation of BMP activity by specific BMP antagonists seems to be a crucial regulatory step.
Currently, over 15 BMP antagonists have been identified and can be classified into four subfamilies, namely, the differential screening-selected gene aberrative in neuroblastoma (DAN, official symbol NBL1) subfamily, the twisted gastrulation subfamily, the chordin/noggin subfamily, and the follistatin-related subfamily. This classification is based on their sequence similarity and cysteine residue arrangement [7, 8] . Of particular interest is the DAN subfamily, which consists of DAN, cerberus, gremlin 1, gremlin 2 (also named PRDC), DAND5 (also named coco), SOST, and SOSTDC (also named USAG-1). This subfamily contains a typical cystine knot arrangement like BMPs [7] . It is well known that cystine knot proteins such as glycoprotein hormones, BMP members, and platelet-derived growth factors play important roles in embryonic development, organogenesis, and tissue remodeling [9] . However, although members of the DAN subfamily display a typical cystine knot signature, their physiological functions, as well as their involvement in the spatial and temporal control of BMP actions, have not yet been explored in detail.
DAN is the founding member of the DAN subfamily. It was originally proposed to be a tumor suppressor gene based on its transcriptional pattern, whereby it was significantly downregulated in v-src-transformed rat fibroblasts [10, 11] . In Xenopus animal cap assays, overexpression of DAN shows features of a BMP signaling blockade, including induction of cement glands, as well as markers of anterior neural tissue and endoderm [12] . This suggests that DAN acts as a potential BMP antagonist. Using an indirect binding assay [13] , DAN has been shown to bind to BMP2 in vitro. A Xenopus embryo injection study suggested that DAN is also able to interact with GDF5 [14] . However, no direct antagonizing activity of DAN on any BMP has been reported. Additionally, in contrast to Bmp2-null and Gdf5-null mice, which show lethality and shorter bone formation, respectively, DAN-null mice exhibit no apparent phenotype [14] . Therefore, whether DAN is able to regulate any specific BMP function under physiological conditions remains to be demonstrated. Here we generated functional recombinant DAN protein and characterized its antagonizing spectrum relative to diverse BMP families. We further demonstrated that DAN acts as a modulator that balances GDF9 and BMP signaling during ovarian folliculogenesis.
MATERIALS AND METHODS

Experimental Animals
Sprague-Dawley rats were obtained from the Laboratory Animal Center of the National Yang-Ming University. For time-course analyses of DAN transcripts using the superovulation model, immature female rats at 26 days of age were primed with 15 IU of equine chronic gonadotropin (eCG) between 0900 h and 1000 h and received an i.p. injection of 10 IU of human chorionic gonadotropin (hCG) 48 h later. Rats were then sacrificed at different time points, and the ovaries or different ovarian compartments were collected for cDNA preparation. All animals were housed under a controlled humidity, temperature, and light regimen and fed standard rat chow ad libitum. Animal care and experiments were approved by the Institutional Animal Care and Use Committee of the National Yang-Ming University (Permit 981205).
Hormones and Reagents
Human follicle-stimulating hormone (FSH), eCG, and hCG were purchased from Calbiochem (La Jolla, CA). Recombinant human DAN-Fc, BMP2, BMP4, BMP6, BMP7, GDF5, anti-Mullerian hormone (AMH), TGFB, GDF9, and activin were purchased from R&D Systems (Minneapolis, MN). McCoy 5A medium, L-15 Leibovitz medium, Dulbecco modified Eagle medium-F12 (DMEM), L-glutamine, penicillin, and streptomycin were obtained from Invitrogen Life Technologies (Carlsbad, CA). The anti-FLAG monoclonal antibody M1, anti-FLAG M1 affinity gel, anti-progesterone antibody, progesterone, estradiol, androstenedione, 3-isobutyl-1-methylxanthine, 8-bromo-cAMP, forskolin, and other chemicals (unless noted) were purchased from Sigma (St. Louis, MO).
Sequence Analysis
The sequences of human DAN and other members in the DAN subfamily were identified from the GenBank database (accession numbers: human DAN, BAA92265; human gremlin 1, AAC39725; human gremlin 2, AAH46632; human DAND5, BAC82440; human cerberus, AAK92484). The sequence alignment and phylogenetic tree were constructed by the neighbor-joining method using the MEGALIGN program in the DNASTAR v5.0 software package (DNASTAR, Madison, WI).
Expression and Purification of Recombinant Human DAN Proteins
The full-length human NBL1 (DAN) cDNA was amplified from a human ovary cDNA library (CLONTECH, Palo Alto, CA). To facilitate protein purification, the original signal peptide was replaced with a prolactin signal peptide followed by a FLAG epitope tag before being cloned into the pcDNA3.1/Zeo (þ) expression vector. To introduce a mutated residue into DAN, PCR-based mutagenesis was performed using overlapping primers containing mutated sequences. The primer sequences used were: N39Q forward, CTGGTGCGAAGCCAAGCAGATCACCCAGATCGTGG; N39Q reverse, CCACGATCTGGGTGATCTGCTTGGCTTCGCACCAG. The constructed plasmid was transfected into diverse mammalian cells using Lipofectamine 2000 (Invitrogen Life Technologies). For cell line selection, transfected cells were selected by the Zeocin-containing DMEM medium. Transfected or selected cells were allowed to reach confluence and then cultured for 72 h in the serum-free medium. After filtration, the conditioned medium was concentrated to allow protein detection and the bioactivity test. To purify recombinant FLAG-DAN protein, the conditioned medium was passed through anti-FLAG M1 affinity gel (Sigma). Measurement of the protein content was carried out by Micro-BCA protein assay kit (Pierce Biotechnology, Rockford, IL). The purity and biochemical characteristics of the purified protein were analyzed by electrophoresis on a 12% SDS polyacrylamide gel.
Antiserum Preparation and Western Blot Analysis
Anti-human DAN antibody was generated from immunized rabbits using recombinant human DAN protein purified from Escherichia coli. Briefly, the full-length cDNA of human DAN was subcloned into a pET21a vector (Novagen, EMD Biosciences, CA 
Reporter Assays
The BMP responsive element (BRE)-driven luciferase reporter plasmid [15] and CAGA-driven luciferase reporter plasmid [16] were provided by Drs. O. Korchynskyi (University of North Carolina, Chapel Hill) and C.H. Heldin (Ludwig Institute for Cancer Research, Uppsala, Sweden), respectively. The cell transfection and luciferase assay were performed as described previously [4] . Briefly, COS7 cells transfected with the luciferase reporter and CMV-bGal plasmids were treated with appropriate combinations of TGFB-related ligands and FLAG-DAN or DAN-Fc for overnight. After treatment, the cells were lysed with lysis buffer (Promega Corp., Madison, WI) for subsequent measurement of luciferase and b-galactosidase activity.
Isolation of Ovarian Cells, Culture of Granulosa Cells, and Assessment of Progesterone Production
To obtain granulosa cells and theca-interstitial shells, the ovaries from rats after the above indicated treatments were microdissected in Leibovitz L-15 medium by puncturing under a stereomicroscope (Nikon Instruments). Granulosa cells and theca-containing shells were individually collected and their purity was confirmed based on the differential expression of FSHR and LHR transcripts, which were determined by real-time PCR relative to b-actin (granulosa cells before eCG: FSH receptor, 0.0030; LH receptor, 0.0022; theca cells before eCG: FSH receptor, 0.0016; LH receptor, 0.0092; granulosa cells after eCG: FSH receptor, 0.0045; LH receptor, 0.0358; theca cells after eCG: FSH receptor, 0.0010; LH receptor, 0.0405) [17] . For precisely isolating the various ovarian cell types, the ovaries harvested from immature rats at 26 days of age or eCG-primed rats at 48 h after hCG treatment were frozen and cut into 8-lm sections. The slides were then counterstained and subjected to microdissection using an Arcturus PixCell II laser capture microdissection system (Arcturus Engineering, Mountain View, CA).
For granulosa cell cultures, immature rats at 22 days of age were implanted with diethylstilbestrol-containing capsules. At 72 h after implantation, the ovaries were harvested and punctured in L-15 Leibovitz medium. Granulosa cells from early antral follicles were collected and cultured as described previously [18] . For measurement of progesterone production, granulosa cells (2 3 10 5 viable cells per milliliter) were cultured in McCoy 5A medium in the presence or absence of different hormones. Medium was supplemented with 10 À7 M androstenedione designed to mimic physiological conditions for better maintenance of granulosa cells in vitro. At 48 h after culture, the supernatant was collected and the amount of progesterone was measured by enzyme-linked immunosorbent assay using specific antiprogesterone antibody.
Complementary DNA Isolation, PCR Amplification, and Real-Time PCR Quantification
To analyze changes in DAN transcript level in rats, the target tissues or treated ovarian cells were harvested, and their total RNAs were extracted using TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer's instructions. For first-strand cDNA synthesis, 5 lg of total RNA were reversetranscribed using a RevertAidTM first-strand cDNA synthesis kit (Fermentas, Hanover, MD) with an oligo (dT) primer. For semiquantitative PCR, the primer pairs for each gene were as follows: rat Nbl1 (DAN), TTGGA AGGTGAAGTGTGGTCTT (forward) and GGAAGAAGGAGTGGATAG AATAAGG (reverse); and rat b-actin (Actb), TGACAGACTAC CTCATGAAGATCC (forward) and CTGCTTGCTGATCCACATCTG (reverse). For quantitative TaqMan real-time PCR, a QuantiTect probe PCR kit (Qiagen, Valencia, CA) was used. The primer pairs and fluorescent probes for each gene were as follows: rat Nbl1 (DAN), TTGGAAGGTGAAGTG TGGTCTT (forward) and AGCTCAACCTGCTTCCTCTCTAT; rat Nbl1 (DAN) probe, TTCAGCCTTCTGGAGAGGAGCC; b-actin (Actb), CTCTGTGTGGATTGGTGGCTC (forward) and CTGCTTGCTGATCCA CATCTG (reverse); and b-actin (Actb) probe, CCTGGCCTCACT GTCCACCTTCC.
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Data Analysis
All experimental data are presented as the mean 6 SD of triplicate cultures or samples, with at least two extra experiments showing similar results. For comparisons of significant difference, the values were subjected to analysis by one-way ANOVA followed by Bonferonni post-test using Prism5 demo software (Graphpad Software, Inc., San Diego, CA). Significance was accepted at P , 0.05 and is indicated by asterisks in the figures unless noted otherwise.
RESULTS
Generation and Biochemical Characteristics of Recombinant Human DAN Protein
We aligned the core cystine knot-containing sequences between DAN and other phylogenetically close members such as gremlin 1, gremlin 2, DAND5, and cerberus (Fig. 1A) . DAN shows about 33% identity to other members in this region. Interestingly, in addition to the first nine cysteine residues that are conserved in other members, DAN contains an extra cysteine, C 10 , at the C-terminus. Based on the known cystine knot structure [9] , we predicted this extra cysteine can form an additional intramolecular disulfide bond with C 5 (Fig. 1B) , which is thought to be involved in the formation of an intermolecular covalent bridge in other members of the DAN subfamily. This suggests DAN is likely to form a noncovalently linked dimer during the posttranslational process but not a covalently linked dimer like other members of this family. Up to the present, the whole tissue expression pattern and the physiological roles of DAN have not yet been clarified. Using PCR to screen 22 different rat tissues, DAN transcript was found to be widely distributed in all tissues (Fig. 1C) .
To further generate recombinant DAN protein that would allow functional exploration, a construct containing the cDNA encoding N-terminal FLAG-tagged human DAN was transfected into two epithelium-derived cell lines, namely HEK-293T and CHO, as well as the fibroblast-derived cell line NIH-3T3. Western blot analyses showed that recombinant DAN protein was capable of being secreted from these transfected cells and that the protein migrated faster after treated with Nglycosidase F (Fig. 2A) . This result demonstrated the N-linked glycosylation nature of recombinant DAN protein. We subsequently evaluated the BMP antagonizing potency of the DAN-containing conditioned media from the different transfected cell lines. Intriguingly, in contrast to the DAN-containing conditioned media from transfected 293T and CHO cells, which showed a negligible antagonizing effect on BMP4 signaling, the DAN-containing conditioned medium from transfected NIH-3T3 cells significantly decreased the BMP4-driven response in a dose-dependent manner (Fig. 2B) ; this suggests that the generation of functional DAN is cell type specific. A sequence search indicated a putative N-linked glycosylated site is located at Asn 39 . To study whether the glycosylation level affects DAN bioactivity, a mutated DAN, in which the N-linked glycosylated site Asn 39 was replaced with Gln, was generated and designated N39Q. The conditioned medium from N39Q-transfected NIH-3T3 cells exhibited a BMP-antagonizing potency similar to that of wild-type DAN (Fig. 2C) , suggesting this N-linked glycosylated modification is unlikely to contribute to the antagonizing function of DAN.
To further evaluate the protein nature and bioactivity of DAN, recombinant FLAG-tagged DAN protein was purified from the conditioned media of transfected NIH-3T3 cells, and its purity was confirmed by Coomassie blue staining. Under reducing conditions, purified FLAG-DAN migrated as a band at ;30 kDa (Fig. 3A, lane 2) , whereas it migrated as a diffused band between 30 and 36 kDa under nonreducing conditions (Fig. 3A, lane 4) . In contrast, FLAG-DAN migrated as a band at ;60 kDa after the protein was treated with a cross-linking reagent (Fig. 3A, lane 3) ; this indicated that recombinant FLAG-DAN protein is a noncovalently linked homodimer, which is consistent with the prediction shown in Figure 1B . In addition, Western blotting indicated that a purchased human DAN-Fc recombinant protein, of which the DAN C-terminus is fused with an Fc domain to enforce the dimer formation, is a covalently linked homodimer (Fig. 3A, right panel) . Therefore, both FLAG-DAN and DAN-Fc recombinant proteins were subjected to antagonist assessment. Taking advantage of the BRE-driven luciferase reporter assay, FLAG-DAN can antagonize the BMP4-induced luciferase activity in a dose-dependent manner (Fig. 3B) . When compared with FLAG-DAN, DAN-Fc showed about a 100-fold higher potency in antagonizing the BMP4 activity. In addition, FLAG-DAN generated from CHO cells, which showed less BMP antagonizing potency (Fig. 2B) , was further purified and tested. In contrast to FLAG-DAN from NIH-3T3 cells that inhibited the BMP4-induced luciferase activity by 75% at 100 nM (Fig. 3B ), FLAG-DAN purified from CHO cells can only suppress the activity by 15% at the same concentration. Therefore, we further studied whether the efficiency of protein dimerization is different in these two recombinant proteins. Surprisingly, when compared with the bioactive FLAG-DAN from NIH-3T3 cells, the recombinant FLAG-DAN purified from transfected CHO cells exhibited a similar dimeric characteristic in a cross-linking condition (Fig.  3C) ; this suggests the bioactive potency of DAN is not only determined by protein dimerization. Such a potency difference, which will be discussed later, may be due to the accuracy of intersubunit arrangement when the dimer is formed.
Assessment of the Antagonizing Targets of DAN
Up to the present, the antagonizing specificity of DAN has not been characterized. Taking advantage of the promoterdriven luciferase reporter assays that respond to stimulation of diverse TGFB members, we screened the antagonizing targets of DAN. Specifically, certain members in the TGFB superfamily that have been reported to be important in ovarian function were selected. Using the BRE-driven luciferase reporter assay that efficiently reflects the stimulation of BMP2, BMP4, BMP6, BMP7, BMP10, GDF5, or AMH, we found that cotreatment with FLAG-DAN specifically suppressed the luciferase activity induced by BMP2 and by BMP4, but not that induced by the other family members tested (Fig.  4A) . Using the CAGA-driven luciferase reporter assay that efficiently reflects the stimulation of TGFB, GDF9, or activin, cotreatment with FLAG-DAN showed negligible effect on the luciferase activity induced by these TGFB members (Fig. 4B) . Similar results were obtained when the cotreatment was DANFc (Fig. 4, C and D) . These findings lead to the conclusion that DAN specifically antagonizes BMP2 and BMP4 but not any other tested member of the TGFB superfamily.
The Expression, Distribution, and Regulation of DAN in the Ovary
Current studies indicate that many members in the TGFB superfamily are co-expressed in the ovary, but their availability in different ovarian compartments is further constrained by
FIG. 2. Generation of functional recombinant DAN protein.
A) Conditioned media harvested from different cell lines transfected with a FLAG-DAN-containing construct were used for Western blotting against the FLAG tag. Some samples were treated with peptide N-glycosidase F (PNGase F) to remove N-linked carbohydrate side chains. B) COS7 cells were transfected with BRE-luciferase and CMV-bGal constructs, followed by treatment with BMP4 (1 nM), different volumes of vector-transfected control media (C.M.), or recombinant FLAG-DAN containing media from transfected 293T, CHO, or NIH-3T3 cells in 24-well plates as indicated. C) Equal volumes of conditioned media collected from vector-transfected control, wild-type, or mutated FLAG-DAN (N39Q)-transfected NIH-3T3 cells were subjected to BRE-luciferase assays to compare their antagonizing ability against BMP4. Western blotting against the FLAG tag was performed to confirm the expression and molecular sizes of recombinant proteins. For luciferase assays, the data were normalized against the b-galactosidase levels to correct for transfection efficiency and are expressed as the mean 6 SD of triplicate determinations (*P , 0.05). Two extra experiments showed similar results.
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their corresponding antagonists, which control their actions coordinately but not redundantly [5] . Therefore, we speculated that DAN may play a role in the ovary by regulating the bioactivity of ovarian BMP2 and/or BMP4. Using the superovulated rat model, Nbl1 (DAN) mRNA level showed an immediate increase 1 h after eCG or hCG injection, whereas its transcript was suppressed 6 h after hCG injection and then maintained at a low level for at least 4 days (Fig. 5A ). We subsequently analyzed the level of DAN transcript in different ovarian compartments by separating granulosa cells from theca-interstitial shells. As shown in Figure 5B , granulosa cells exhibited a higher level of DAN transcript than thecainterstitial shells in the ovary either before or at 48 h after eCG injection. To clarify the possible mechanisms underlying the modulation of DAN transcript level by gonadotropins, we further isolated immature granulosa cells from diethylstilbestrol-primed female rats and cultured them with or without FSH for different intervals. As shown in Figure 5C , DAN transcript level was increased in a time-dependent manner when cells were treated with FSH for 6 to 24 h and returned to the basal level after FSH treatment for 48 h. It has been known that gonadotropin actions in the ovary lead to a prompt increase in the cAMP level, which subsequently facilitates the synthesis and release of steroid hormones; based on this, we further tested the effect of these downstream effectors of gonadotropins on Nbl1 (DAN) mRNA expression. We found that treatment with graded doses of forskolin that increases the endogenous cAMP level can significantly increase DAN expression in cultured immature granulosa cells. In contrast, neither estradiol nor progesterone treatment showed any effect on DAN transcript level (Fig. 5D) .
Among the selected TGFB members that are important in ovarian development, we have demonstrated that DAN specifically antagonizes the action of BMP2 and BMP4 (Fig.  4) . Therefore, we further analyzed the differences in spatial distribution of Nbl1 (DAN), Bmp2, and Bmp4 mRNAs. PCR amplification using serially diluted cDNA templates isolated from different ovarian compartments confirmed that DAN transcript was present mainly in granulosa cells and was lowest in corpora lutea. Interestingly, DAN transcript showed a distinct spatial difference from Bmp4, which is mainly expressed in theca-interstitial shells. This contrasts with Bmp2, which is mainly expressed in granulosa cells and corpora lutea, while Gdf9 is mainly located in oocytes (Fig.  6A) . Using cultured immature granulosa cells, we found that DAN transcript was significantly increased when these cells were treated with either BMP4 or GDF9 for 3 h. After prolonged treatment for 12 h and 24 h, GDF9 continued to stimulate Nbl1 (DAN) mRNA expression (Fig. 6B) . We also observed that GDF9 can increase DAN transcript level in a dose-dependent manner (Fig. 6C) . However, contrary to BMP4, which no longer maintained the augmentation of DAN transcript in a prolonged incubation, BMP2 significantly increased Nbl1 (DAN) mRNA expression when granulosa cells were treated for 12 h and 24 h (Fig. 6B) . Since granulosa cells express BMP2 endogenously, we therefore wondered whether 
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BMP2 can elevate its own gene expression through an autoregulatory loop; this would further contribute to induction of DAN transcript level. Of interest, in contrast to being induced transiently by BMP4 at 12 h after treatment, BMP2 transcript level in granulosa cells was indeed elevated timedependently by BMP2 itself for at least 24 h (Fig. 6D) .
DAN Antagonized the BMP4-Induced Suppression of Progesterone Production by Treated Granulosa Cells
Previous studies have shown that BMP4 plays a role in ensuring follicle maturation by suppressing FSH-induced progesterone production in granulosa cells [19] . Based on this, we evaluated the antagonizing effect of DAN on BMP4 activity in the ovary. Using cultured immature granulosa cells, cotreatment with either purified FLAG-DAN or DAN-Fc showed no direct effect on FSH-induced progesterone production. In contrast, BMP4 significantly suppressed the FSH-induced progesterone production by 75%, and this suppression could be totally reversed by cotreatment with either purified FLAG-DAN or DAN-Fc (Fig. 7) .
DISCUSSION
DAN is the founding member of the DAN subfamily. To our knowledge, this is the first report describing production of functional DAN protein and analyzing its physiological functions directly. We demonstrated that N-linked glycosylation does not affect the bioactivity of DAN (Fig. 2C) . However, our results also suggest that production of bioactive DAN protein may require cell-specific, yet-unidentified, folding machinery (Figs. 2B and 3C) . It is interesting to note that, unlike most BMPs and other BMP antagonist members in the DAN subfamily, which form covalently linked dimers [7] , DAN contains an even number of cysteine residues and forms a noncovalently linked homodimer (Figs. 1A and 3A) . Therefore, the accuracy of dimerization between two monomers, as described below, may explain the bioactivity difference of recombinant DAN proteins produced from different cells. It has been known that the arrangement between the two monomers of cystine knot dimers is important to their bioactivity. For example, the two monomers of most TGFB molecules, like BMP7, exhibit extended symmetric arrangements with the finger structures of the cystine knot pointing outward. However, activin is shown to adopt a compact folded-back conformation that results in shading of the wrist region of the cystine knot structure and a pointing of the fingers of the monomers in nearly the same direction rather than outward [20, 21] . The stacking angle between the two monomers depends on the molecular interaction at the dimeric interface, in which stabilization is not only attributable to hydrophobic interactions between the monomers but is also further strengthened by the presence of an intersubunit disulfide bridge. Therefore, we speculated that the lack of an intermolecular disulfide bond between two DAN monomers may weaken the subunit interaction, and additional folding machinery may be needed to ensure the correct dimer arrangement during protein folding. Such folding machinery may be cell type-specific and, thus, this might limit the generation of the bioactive DAN protein to certain cells. Likewise, the necessity of correct dimerization may also explain why DAN-Fc recombinant protein, for which the covalently linked Fc tag may coincidentally help the correct intersubunit stacking of DAN homodimer during folding, exhibited a much higher BMP antagonizing potency (Fig. 3) .
Our results showed that DAN can specifically antagonize the bioactivity of BMP4 and BMP2 (Fig. 4) , whereas Nbl1 (DAN) mRNA expression in rat ovarian granulosa cells was strongly up-regulated by GDF9 (Fig. 6) . Of interest, a previous study [5] in combination with our ovarian expression results in Figure 6A indicate that GDF9 forms an inverse gradient to BMP4 and BMP2 during folliculogenesis. Thus, taken together with its antagonizing specificity and regulatory pattern, DAN may contribute to the balance of these BMP actions in a spatial and temporal manner during the stage of follicular growth and development. For example, the DAN gradient, which originates from up-regulation by oocyte-derived GDF9, may shield cumulus cells and granulosa cells in the inner follicular layers from contact with BMP2 and BMP4; this allows GDF9 or other oocyte-derived factors to influence these cells in maintaining their proliferation and survival [22] . In contrast, outside the coverage of antagonist gradient, theca-derived BMP4 and granulosa/theca-derived BMP2 can work in concert to ensure cell differentiation and maturation by enhancing FSH-stimulated estradiol production in the outer granulosa layers and suppressing LH-induced androgen secretion in theca layers [19, [23] [24] [25] . Thus, the DAN gradient may allow these local ovarian autocrine and paracrine factors to direct cells within different follicular compartments toward diverse fates without interfering with each other.
Furthermore, we demonstrated that DAN transcript was transiently up-regulated by gonadotropins, which is likely to occur through the cAMP/PKA pathway. We also showed that the elevation of Nbl1 (DAN) mRNA expression returns to the basal level in the superovulated rats at 48 h after eCG injection or is further suppressed 6 h after hCG injection (Fig. 5A) . A similar effect was also observed in cultured granulosa cells treated with FSH for 48 h (Fig. 5C ). Although we speculated that the down-regulation of DAN transcript may be caused by the downstream effectors of gonadotropins, such as steroids, we did not observe any response of estrogen and progesterone on inhibition of Nbl1 (DAN) mRNA level (Fig. 5D) . Therefore, such a down-regulation may be controlled by other regulatory factors, as yet not characterized, that are expressed as a consequence of gonadotropin signaling and/or the luteinization process.
In addition, we observed that treatment with BMP2 and BMP4 showed different effects on Nbl1 (DAN) and Bmp2 mRNA expression in granulosa cells. BMP4 can only transiently augment DAN and BMP2 transcripts, whereas BMP2 continues to stimulate Nbl1 (DAN) and Bmp2 mRNA expression for at least 24 h (Fig. 6, B and D) . Although BMP2 and BMP4 are capable of activating the same population of FIG. 5. Expression and regulation of DAN in the ovary. Rats at 26 days of age were treated with eCG, followed 48 h later with hCG. The ovaries or different ovarian cell types collected at the indicated intervals were used for cDNA preparation. DAN transcripts in the whole ovary (A) or in granulosa cells (GC) and theca shells (TS) isolated from ovaries before and at 48 h after eCG treatment (B) were compared by real-time PCR quantification (n ¼ 3). Granulosa cells isolated from immature rats were cultured with or without 1 nM FSH for different time intervals (C) or with graded doses of forskolin, estradiol (E 2 ), or progesterone (P 4 ) for 12 h (D; n ¼ 4). DAN transcript levels were then determined by real-time PCR. Data were normalized using the bactin levels and are shown as the mean 6 SD (*P , 0.05).
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type I and type II BMP receptors [1] , their relative affinity to each receptor heterodimer has not yet been determined. Thus, the different effects between BMP2 and BMP4 on granulosa cells may be due to the uncharacterized BMP receptor combination on the cell surface, which then results in subtle differences in the subsequent feedback loop. This complicated feedback loop may also adjust the differences of stimulating duration and intensity between BMP2 and BMP4 in granulosa cells, thus allowing cells to select the correct BMP types during folliculogenesis.
Similar to parts of our findings, Pangas et al. [26] have proposed that GDF9 can up-regulate production of gremlin 1, a member in the DAN subfamily, in oocyte-surrounding cumulus cells and granulosa cells, thus suppressing BMP4-induced prostaglandin E2 accumulation in these cells. Sudo et al. [27] also have reported that gremlin 2 can be specifically expressed in granulosa cells, where it may reverse the BMP4 effects on inhibition of FSH-induced progesterone production. However, contrary to our data that showed moderate Nbl1 (DAN) mRNA expression in theca cells, gremlin 1 and gremlin 2 transcripts are not detected in theca cells and oocytes of any follicular stage. Whether FSH and BMP2 have any modulating effect on gremlin 1 and gremlin 2 expressions has also not been explored in these studies. Furthermore, unlike DAN and gremlin 1, which specifically inhibit BMP2 and BMP4, gremlin 2 exhibits FIG. 6. BMP4, BMP2, and GDF9 show different spatial distribution compared with DAN in the ovary and exhibit different effects on DAN expression. A) Granulosa cells, theca shells, oocytes (OC) from rats at 26 days of age, and corpora lutea (CL) from eCG-primed rats at 48 h after hCG treatment were isolated by laser capture microdissection to assess the transcript location of DAN, Bmp4, Bmp2, and Gdf9. b-actin (Actb) served as an internal control. PCR, 30 cycles. In addition, granulosa cells isolated from immature rats were cultured with or without BMP2 (1 nM), BMP4 (1 nM), or GDF9 (3 nM) for different time intervals (B) or graded doses of GDF9 for 12 h (C). DAN transcript levels were then determined by real-time PCR (n ¼ 3). D) To study the effects of BMP2 and BMP4 on Bmp2 gene expression in granulosa cells, BMP2 transcript levels were further quantified in granulosa cells treated with BMP2 or BMP4 for different time intervals (n ¼ 3). Data were normalized using the b-actin levels and are shown as the mean 6 SD (*P , 0.05).
FIG. 7.
Recombinant DAN proteins antagonize the suppressive effect of BMP4 on the FSH-induced progesterone production in granulosa cells. Granulosa cells isolated from immature rats were treated with buffer, FLAG-DAN (300 nM) or DAN-Fc (3 nM) only, or FSH (0.1 nM) in combination with BMP4 (1 nM) and FLAG-DAN (300 nM) or DAN-Fc (3 nM) as indicated. The progesterone levels in cultured media were determined 48 h after treatment. Data are shown as the mean 6 SD (n ¼ 3; *P , 0.05).
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additional antagonizing effects on BMP6 and BMP7 [27] . In addition to the DAN family, other BMP antagonists, such as follistatin, have also been found to be expressed in granulosa cells. Follistatin can suppress the follicular development and ovulation rate through blocking activin actions [28] . Follistatin binds with high affinity to activin and with lower affinities to some BMP ligands such as BMP4, BMP6, and BMP7. This allows follistatin to differentially modulate activin and BMP actions in the ovary [29] . Therefore, based on their antagonizing specificity, the potency against various TGFB members, and the distinct signals that induce them, these ovarianexpressed BMP antagonists may work as a complementary but as yet unclear network that maintains diverse BMP and TGFB activities in both a spatial and temporal manner. Interestingly, recent studies also show that other BMP antagonists exhibit additional bioactivities. For example, gremlin 1 can bind directly to vascular endothelial growth factor receptor 2, whereas the binding of gremlin 1 to vascular endothelial growth factor receptor 2 is independent of complex formation with BMPs [30] . Gremlin 1 belongs to the DAN subfamily, and both its antagonizing specificity and ovarian regulatory pattern are similar to DAN. Thus, whether DAN may exert another function, also perhaps in angiogenesis, needs to be further characterized in the future.
